Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)
Status:
Completed
Trial end date:
2007-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of combination therapy of radiotherapy
and temozolomide ("concomitant radiotherapy phase"), and then temozolomide monotherapy
("monotherapy phase"), in patients with newly diagnosed glioblastoma multiforme. Progression
free survival and response rate will also be calculated.